We report the increasing prevalence of the synthetic cannabinoid receptor agonist (SCRA) ADB-BUTINACA (N-[1-amino-3,3-dimethyl-1-oxobutan-2-yl]-1-butyl-1H-indazole-3 …
我们报告了合成大麻素受体激动剂 (SCRA) ADB-BUTINACA ( N -[1-amino-3,3-dimethyl-1-oxobutan-2-yl]-1-butyl-1 H ) 的日益流行-吲唑-3-羧酰胺）。ADB-BUTINACA 于 2019 年在瑞典的 …
ADB-BUTINACA was detected in blood from patients with suspected drug intoxications, as well as in blood, kidney and liver samples collected during postmortem investigations. …
ADB-BUTINACA CAS 登记号 物质唯一标识(Unique Ingredient Identifier) ZJ6LS4NVM9 分子式 C18H26N4O2 国际化合物标识(International Chemical Identifier,InChI) GPWADXHYJAZPAX …
ADB-BUTINACA is likely to have emerged onto the illicit drug market in late 2019, when it was first detected in Sweden in a seized sample and where its possible metabolites were identified …
更多内容请点击：The metabolism of the synthetic cannabinoids ADB-BUTINACA and ADB-4en ... 推荐文章